Skip to main content
Clinical Trials/NCT03752411
NCT03752411
Completed
Not Applicable

The Use of Nomi Technology to Monitor Opioid Use

The University of Texas Medical Branch, Galveston1 site in 1 country96 target enrollmentDecember 5, 2018
ConditionsChronic Pain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Pain
Sponsor
The University of Texas Medical Branch, Galveston
Enrollment
96
Locations
1
Primary Endpoint
total nausea scale
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of the study is to test a research prescription bottle that will monitor the physical environment inside the bottle.

Detailed Description

The purpose of the study is to test a research prescription bottle that will monitor the physical environment inside the bottle. The participant will be asked to keep the medication in the bottle and to remove each pill immediately before taking it. The participant will not store medications in pill organizers, other pill bottles, pockets, purses, etc. The participant will keep a record of when the participant removes a pill from the bottle and takes it. Certain aspects of this study will be withheld from the participant to preserve the integrity of the study. This information will be revealed at the conclusion of the study.

Registry
clinicaltrials.gov
Start Date
December 5, 2018
End Date
November 5, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • chronic pain \> 3 months duration
  • major source of pain is due to low back pain diagnosis
  • prescribed only one type of opioid: hydrocodone 10mg/325 mg acetaminophen
  • Last urine drug study was done between 6-12 months ago
  • will have a return to clinic visit in 3 months

Exclusion Criteria

  • concurrent use of other opioids
  • use of intrathecal device
  • use of spinal cord stimulator
  • presence of pain due to cancer, chemotherapy, radiation treatment and/or cancer related surgery
  • illiteracy

Outcomes

Primary Outcomes

total nausea scale

Time Frame: day 90

On a scale of 0-3 where 0=no nausea, 1= mild, 2= moderate, and 3= severe

total medication dose

Time Frame: day 90

pain medication dose (mg)

total vomiting scale

Time Frame: day 90

On a scale of 0-3 where 0=no vomiting, 1= mild, 2= moderate, and 3= severe

total type of bowel movement

Time Frame: day 90

choose one of the following: hard, soft, loose

total Pain scale

Time Frame: day 90

On a scale of 0-10 where 0 is no pain and 10 is the worst pain ever felt.

overall satisfaction with pain control

Time Frame: day 90

0-10 scale where 0 is dissatisfied and 10 is very satisfied

total sedation scale

Time Frame: day 90

On a scale of 0-3 where 0=no sedation, 1= mild, 2= moderate, and 3= severe

total bowel movements

Time Frame: day 90

number of bowel movements (whole number)

Secondary Outcomes

  • Barretts impulsivity questionnaire(day 90)
  • opioid related behavior in treatment questionnaire(day 90)
  • prescribed opioids difficulty scale(day 90)

Study Sites (1)

Loading locations...

Similar Trials